ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Fuel Cycle & Waste Management
Devoted to all aspects of the nuclear fuel cycle including waste management, worldwide. Division specific areas of interest and involvement include uranium conversion and enrichment; fuel fabrication, management (in-core and ex-core) and recycle; transportation; safeguards; high-level, low-level and mixed waste management and disposal; public policy and program management; decontamination and decommissioning environmental restoration; and excess weapons materials disposition.
2020 ANS Annual Meeting
June 8–11, 2020
Online Virtual Meeting
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Latest Journal Issues
Nuclear Science and Engineering
Fusion Science and Technology
Base for second Hinkley Point C reactor completed
Concrete pour at the Hinkley Point C2 reactor. Photo: EDF Energy
Workers at the Hinkley Point C nuclear construction project in the United Kingdom have completed the 49,000-ton base for the station’s second reactor, Unit C2, hitting a target date set more than four years ago, according to EDF Energy.
Challenge: Ensure continuous availability of radioisotopes.
How: Develop a dependable technical approach to ensure the continued availability of radioisotopes — including rare, short-lived, less available radionuclides for medical, energy, research (aerospace, nondestructive analysis), and national security applications.
Background: U.S. domestic production of key radioactive and stable isotopes has significantly diminished, leaving patients and industry vulnerable to disruptions of our mostly foreign supply. New diagnostic and therapeutic agents are not being developed due to the lack of a reliable isotope supply, and difficult investment and regulatory climates.
Last modified May 12, 2017, 1:22am CDT